1. Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment.
- Author
-
Mohamed R, Wang W, Tanwandee T, Hasan I, Pham CP, Lim YS, Lu SN, Munisamy M, Tran TTH, Ratnawati E, Sukeepaisarnjaroen W, Karababa M, and Tan CK
- Subjects
- Humans, Male, Cross-Sectional Studies, Female, Asia epidemiology, Middle Aged, Surveys and Questionnaires, Risk Factors, Physicians psychology, Physicians statistics & numerical data, Adult, Aged, Health Knowledge, Attitudes, Practice, Early Detection of Cancer statistics & numerical data, Early Detection of Cancer methods, Quality of Life, Liver Neoplasms therapy, Liver Neoplasms diagnosis, Liver Neoplasms epidemiology, Liver Neoplasms pathology, Carcinoma, Hepatocellular diagnosis, Carcinoma, Hepatocellular therapy, Carcinoma, Hepatocellular epidemiology, Carcinoma, Hepatocellular pathology
- Abstract
Purpose: In several Asian countries, hepatocellular carcinoma (HCC) is a leading cause of cancer deaths. HCC risk factors in Asia differ from those elsewhere and are changing with the treatment landscape as systemic treatment options increase. This study was conducted to gain insight from physicians and patients into HCC screening, diagnosis, and treatment strategies in Indonesia, Korea, Malaysia, Singapore, Taiwan, Thailand, and Vietnam., Methods: Two cross-sectional, anonymized, online surveys were completed between July and December 2022 by physicians diagnosing and treating HCC (55 questions on risk factors, surveillance, diagnosis, and treatment) and patients ≥ 18 years old diagnosed with HCC (36 questions on disease knowledge, quality of life, and experiences of diagnosis and treatment)., Results: Responses were received from 276 physicians in all 7 countries and 130 patients in Thailand, Taiwan, and Vietnam. From the physician's perspective, surveillance programs are widespread but identify insufficient HCC cases; only 18% are early-stage HCC at diagnosis. From the patient's perspective, knowledge of risk factors increases after diagnosis, but few seek support from patient associations; patients would benefit from better communication from their doctors. Treatment affordability and side effects are key issues for patients., Conclusions: Awareness of the risk factors for HCC should be raised in primary care and the general population, and surveillance should identify early-stage HCC. Because patients rely on their doctors for support, doctors should better understand their patients' needs, and patients could be supported by trained nurses or case managers. Programs are needed to increase patients' access to proven HCC treatments., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF